Armistice Capital’s Cyclo Therapeutics, Inc. Warrant CYTHW Stock Holding History

Armistice Capital’s Portfolio CYTHW Stock Details CYTHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50,000	Closed	-$156K	–	135
2020 Q4	$156K	Buy	+50,000	New	+$61.7K	0.01%	106

Other funds holding CYTHW

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Armistice Capital's CYTHW Position: Q1 2021 in Review

Armistice Capital sold out of Cyclo Therapeutics, Inc. Warrant (CYTHW) in Q1 2021, closing a stake of 50,000 shares — an estimated $156K sold.

Armistice Capital first reported a position in CYTHW in Q4 2020 and held it in 1 quarter. The position peaked at $156K in Q4 2020. 2 funds tracked by Wall St. Rank hold CYTHW as of Q1 2021.

Armistice Capital reported no remaining Cyclo Therapeutics, Inc. Warrant position as of Q1 2021 after selling out during the quarter.
Armistice Capital sold 50,000 Cyclo Therapeutics, Inc. Warrant shares in Q1 2021, an estimated $156K.
Armistice Capital first reported a position in Cyclo Therapeutics, Inc. Warrant in Q4 2020 and held it in 1 quarter.
Armistice Capital's Cyclo Therapeutics, Inc. Warrant position peaked at $156K in Q4 2020.
2 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Warrant as of Q1 2021.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.